首页> 美国卫生研究院文献>International Medical Case Reports Journal >A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
【2h】

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report

机译:低氯氮平剂量改善了耐火性萎缩肌瘤不会加剧精神症状:案例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clozapine is recommended for patients with schizophrenia and tardive dystonia (TD); however, the appropriate dose remains unclear. In this case, a low dose (150 mg/day) of clozapine improved refractory TD and further ameliorated psychiatric symptoms. Herein, we report on a 41-year-old female with schizophrenia and TD who was treated with a low clozapine dose. After eight weeks of continuous clozapine at 150 mg/day (16 weeks after clozapine initiation), her TD dramatically improved, and her psychiatric symptoms were relieved. Low clozapine doses could ameliorate refractory TD. However, this effect might require up to several weeks. Clinicians should be patient unless they consider it better to increase the clozapine dose.
机译:推荐用于患有精神分裂症和迟发性肌瘤(TD)的患者的氯氮平;然而,相应的剂量仍然尚不清楚。在这种情况下,低剂量(150mg /天)的氯氮平改善了难治性Td,进一步改善了精神症状。在此,我们向一名41岁的女性报告有精神分裂症和TD的女性,他用低氯氮平剂量治疗。在150毫克/天的连续氯氮平八周(氯氮平开始后16周)后,她的TD显着改善,她的精神症状得到了缓解。低氯氮平剂量可以改善难治性Td。但是,这种效果可能需要多达几周。临床医生应耐心等待,除非他们认为更好地增加氯氮平剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号